MedTrace Logo

Effect on Patient Reported Outcomes of VATS and SABR (LILAC)

NCT02882750 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 244

Last updated 2019-11-05

No results posted yet for this study

Summary

This study will monitor the effect on patients reported outcomes (PROMs) of VATS resection and SABR for NSCLC delivered at the Leeds Cancer Centre The investigator will support with this information the Shared Decision Making (SDM) process.

300 consecutive patients will be followed up from prior the treatment to 12 months afterwards, administering multiple questionnaires (EORTC QLQ C-30 and LC-13, PSQ-18, Decision Self-Efficacy Scale) by a remote web-based system.

Deliverable:

1. Differences after VATS resections or SABR in terms of physical and psychological symptoms, quality of life and satisfaction
2. Patient perspectives of the Shared Decision Making Process.

Conditions

Interventions

OTHER

EORTC QLQ-C30 (version 3.0).

Quality of Life Questionnaire

OTHER

PS Q18

Patients Satisfaction Questionnaire

OTHER

Decision Self-Efficacy Scale

Questionnaire

Sponsors & Collaborators

  • Yorkshire Cancer Research

    collaborator OTHER

  • The Leeds Teaching Hospitals NHS Trust

    collaborator OTHER

  • University of Leeds

    lead OTHER

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2016-01-25
Primary Completion
2018-04-09
Completion
2019-06-06

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT02882750 on ClinicalTrials.gov